Skip to main content
Erschienen in: Heart and Vessels 3/2021

15.09.2020 | Original Article

Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease

verfasst von: Yuki Deguchi, Yuichi Saito, Motohiro Nakao, Hirokazu Shiraishi, Naoya Sakamoto, Satoru Kobayashi, Yoshio Kobayashi

Erschienen in: Heart and Vessels | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by − 2.3 ml/min/1.73 m2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.
Literatur
1.
Zurück zum Zitat Kidney Disease Improving Global Outcomes (KDIGO) (2012) Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRef Kidney Disease Improving Global Outcomes (KDIGO) (2012) Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRef
2.
Zurück zum Zitat Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380:2146–2155CrossRef Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380:2146–2155CrossRef
3.
Zurück zum Zitat Almendarez M, Gurm HS, Mariani J Jr, Montorfano M, Brilakis ES, Mehran R, Azzalini L (2019) Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention. JACC Cardiovasc Interv 12:1877–1888CrossRef Almendarez M, Gurm HS, Mariani J Jr, Montorfano M, Brilakis ES, Mehran R, Azzalini L (2019) Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention. JACC Cardiovasc Interv 12:1877–1888CrossRef
4.
Zurück zum Zitat Vanmassenhove J, Kielstein J, Jörres A, Biesen WV (2017) Management of patients at risk of acute kidney injury. Lancet 389:2139–2151CrossRef Vanmassenhove J, Kielstein J, Jörres A, Biesen WV (2017) Management of patients at risk of acute kidney injury. Lancet 389:2139–2151CrossRef
5.
Zurück zum Zitat Seto AH, Shroff A, Abu-Fadel M, Blankenship JC, Boudoulas KD, Cigarroa JE, Dehmer GJ, Feldman DN, Kolansky DM, Lata K, Swaminathan RV, Rao SV (2018) Length of stay following percutaneous coronary intervention: an expert consensus document update from the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv 92:717–731CrossRef Seto AH, Shroff A, Abu-Fadel M, Blankenship JC, Boudoulas KD, Cigarroa JE, Dehmer GJ, Feldman DN, Kolansky DM, Lata K, Swaminathan RV, Rao SV (2018) Length of stay following percutaneous coronary intervention: an expert consensus document update from the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv 92:717–731CrossRef
6.
Zurück zum Zitat Abe M, Morimoto T, Nakagawa Y, Furukawa Y, Ono K, Kato T, Kadota K, Ando K, Ishii M, Masunaga N, Akao M, Kimura T (2017) Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention. Am J Cardiol 120:2146–2153CrossRef Abe M, Morimoto T, Nakagawa Y, Furukawa Y, Ono K, Kato T, Kadota K, Ando K, Ishii M, Masunaga N, Akao M, Kimura T (2017) Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention. Am J Cardiol 120:2146–2153CrossRef
7.
Zurück zum Zitat Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J (2020) Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 35:1–12CrossRef Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J (2020) Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 35:1–12CrossRef
8.
Zurück zum Zitat Sonoda S, Hibi K, Okura H, Fujii K, Honda Y, Kobayashi Y (2020) Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions. Cardiovasc Interv Ther 35:30–36CrossRef Sonoda S, Hibi K, Okura H, Fujii K, Honda Y, Kobayashi Y (2020) Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions. Cardiovasc Interv Ther 35:30–36CrossRef
9.
Zurück zum Zitat Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, Shinke T, Kobayashi Y, Ikari Y, Akasaka T (2020) Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography. Cardiovasc Interv Ther 35:13–18CrossRef Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, Shinke T, Kobayashi Y, Ikari Y, Akasaka T (2020) Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography. Cardiovasc Interv Ther 35:13–18CrossRef
10.
Zurück zum Zitat Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32–38CrossRef Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32–38CrossRef
11.
Zurück zum Zitat Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology; Japan Radiological Society, Japanese Circulation Society Joint Working Group (2019) Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Circ J 83:2572–2607CrossRef Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology; Japan Radiological Society, Japanese Circulation Society Joint Working Group (2019) Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Circ J 83:2572–2607CrossRef
12.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035CrossRef Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035CrossRef
13.
Zurück zum Zitat Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed
14.
Zurück zum Zitat Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519CrossRef Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519CrossRef
15.
Zurück zum Zitat Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Weintraub WS, Curtis JP, Messenger JC, Rumsfeld JS, Spertus JA (2014) Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc 3:e001380CrossRef Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Weintraub WS, Curtis JP, Messenger JC, Rumsfeld JS, Spertus JA (2014) Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc 3:e001380CrossRef
16.
Zurück zum Zitat Watanabe M, Saito Y, Aonuma K, Hirayama A, Tamaki N, Tsutsui H, Murohara T, Ogawa H, Akasaka T, Yoshimura M, Sato A, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, CINC-J Study Investigators (2016) Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization. J Cardiol 68:412–418CrossRef Watanabe M, Saito Y, Aonuma K, Hirayama A, Tamaki N, Tsutsui H, Murohara T, Ogawa H, Akasaka T, Yoshimura M, Sato A, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, CINC-J Study Investigators (2016) Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization. J Cardiol 68:412–418CrossRef
17.
Zurück zum Zitat Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, Boulos M, Kapeliovich MR, Beyar R, Nikolsky E, Aronson D (2017) Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc 6:e005715CrossRef Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, Boulos M, Kapeliovich MR, Beyar R, Nikolsky E, Aronson D (2017) Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc 6:e005715CrossRef
18.
Zurück zum Zitat Otsuka K, Shimada K, Katayama H, Nakamura H, Ishikawa H, Takeda H, Fujimoto K, Kasayuki N, Yoshiyama M (2019) Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention. Heart Vessels 34:735–744CrossRef Otsuka K, Shimada K, Katayama H, Nakamura H, Ishikawa H, Takeda H, Fujimoto K, Kasayuki N, Yoshiyama M (2019) Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention. Heart Vessels 34:735–744CrossRef
19.
Zurück zum Zitat Liu Y, Duan CY, Wang K, Bei WJ, Guo XS, Li HL, Wang Y, Chen SQ, Xian Y, Chen PY, Geng QS, Tan N, Chen JY (2017) Could late measurement of serum creatinine be missed for patients without early increase in serum creatinine following coronary angiography? Medicine (Baltimore) 96:e8460CrossRef Liu Y, Duan CY, Wang K, Bei WJ, Guo XS, Li HL, Wang Y, Chen SQ, Xian Y, Chen PY, Geng QS, Tan N, Chen JY (2017) Could late measurement of serum creatinine be missed for patients without early increase in serum creatinine following coronary angiography? Medicine (Baltimore) 96:e8460CrossRef
20.
Zurück zum Zitat Ribichini F, Graziani M, Gambaro G, Pasoli P, Pighi M, Pesarini G, Abaterusso C, Yabarek T, Brunelleschi S, Rizzotti P, Lupo A, Vassanelli C (2010) Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med 123:755–763CrossRef Ribichini F, Graziani M, Gambaro G, Pasoli P, Pighi M, Pesarini G, Abaterusso C, Yabarek T, Brunelleschi S, Rizzotti P, Lupo A, Vassanelli C (2010) Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med 123:755–763CrossRef
21.
Zurück zum Zitat Chia YC, Lim HM, Ching SM (2016) Long-term visit-to-visit blood pressure variability and renal function decline in patients with hypertension over 15 years. J Am Heart Assoc 5:e003825CrossRef Chia YC, Lim HM, Ching SM (2016) Long-term visit-to-visit blood pressure variability and renal function decline in patients with hypertension over 15 years. J Am Heart Assoc 5:e003825CrossRef
22.
Zurück zum Zitat No authors listed (2013) Chapter 2: definition, identification, and prediction of CKD progression. Kidney Int Suppl 3:63–72 No authors listed (2013) Chapter 2: definition, identification, and prediction of CKD progression. Kidney Int Suppl 3:63–72
23.
Zurück zum Zitat Nakahashi T, Tada H, Sakata K, Yakuta Y, Yoshida T, Tanaka Y, Nomura A, Terai H, Horita Y, Ikeda M, Namura M, Takamura M, Kawashiri MA (2020) Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention. Heart Vessels 35:1360–1367CrossRef Nakahashi T, Tada H, Sakata K, Yakuta Y, Yoshida T, Tanaka Y, Nomura A, Terai H, Horita Y, Ikeda M, Namura M, Takamura M, Kawashiri MA (2020) Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention. Heart Vessels 35:1360–1367CrossRef
24.
Zurück zum Zitat Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC (2005) Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med 165:2659–2665CrossRef Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC (2005) Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med 165:2659–2665CrossRef
25.
Zurück zum Zitat Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K (2019) Persistent renal dysfunction in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. J Am Heart Assoc 8:e014096CrossRef Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K (2019) Persistent renal dysfunction in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. J Am Heart Assoc 8:e014096CrossRef
26.
Zurück zum Zitat Katoh H, Nozue T, Horie K, Sozu T, Inoue N, Michishita I (2019) RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study. Cardiovasc Interv Ther 34:105–112CrossRef Katoh H, Nozue T, Horie K, Sozu T, Inoue N, Michishita I (2019) RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study. Cardiovasc Interv Ther 34:105–112CrossRef
27.
Zurück zum Zitat Sakai K, Ikari Y, Nanasato M, Umetsu H, Okutsu M, Takikawa T, Sumitsuji S, Sadamatsu K, Takada M, Kato Y, Ogasawara N, Otowa K (2019) Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease. Cardiovasc Interv Ther 34:234–241CrossRef Sakai K, Ikari Y, Nanasato M, Umetsu H, Okutsu M, Takikawa T, Sumitsuji S, Sadamatsu K, Takada M, Kato Y, Ogasawara N, Otowa K (2019) Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease. Cardiovasc Interv Ther 34:234–241CrossRef
28.
Zurück zum Zitat Coca SG (2013) Is it AKI or nonrecovery of renal function that is important for long-term outcomes? Clin J Am Soc Nephrol 8:173–176CrossRef Coca SG (2013) Is it AKI or nonrecovery of renal function that is important for long-term outcomes? Clin J Am Soc Nephrol 8:173–176CrossRef
Metadaten
Titel
Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease
verfasst von
Yuki Deguchi
Yuichi Saito
Motohiro Nakao
Hirokazu Shiraishi
Naoya Sakamoto
Satoru Kobayashi
Yoshio Kobayashi
Publikationsdatum
15.09.2020
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2021
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01701-1

Weitere Artikel der Ausgabe 3/2021

Heart and Vessels 3/2021 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.